Clinical Trials Logo

Clinical Trial Summary

Healthy volunteer subjects will receive retinoid QLT091001 once-daily for 7 days for safety observation.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label


Related Conditions & MeSH terms


NCT number NCT00765427
Study type Interventional
Source QLT Inc.
Contact
Status Completed
Phase Phase 1
Start date September 2008
Completion date March 2009

See also
  Status Clinical Trial Phase
Completed NCT04339283 - Effect of Standardized Hibiscus Sabdariffa Tea in Seemingly Healthy Human Volunteers N/A
Completed NCT00813670 - Single and Multiple Ascending Dose Safety Study of XPF-001 in Healthy Volunteers Phase 1
Completed NCT02219438 - Continuous Adductor Canal Nerve Blocks: Relative Effects of a Basal Infusion v. Hourly Bolus Doses Phase 4